Sirona Biochem Corp. announced the termination of the Rodan + Fields agreement for supply and use of TFC-1067 in commercial formulations. Allergan Aesthetics, will now be the sole licensee of the technology as per the agreement signed June 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 CAD | 0.00% | -14.29% | -50.00% |
04-08 | Sirona Biochem Provides Update on Anti-Aging Product | MT |
04-04 | Sirona Biochem Corp. announced that it has received CAD 0.1325 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-50.00% | 11.31M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- SBM Stock
- News Sirona Biochem Corp.
- Sirona Biochem Corp. Announces the Termination of Supply Agreement with Rodan+Fields